InvestorsHub Logo
Followers 5
Posts 721
Boards Moderated 0
Alias Born 10/17/2007

Re: FSAIL52 post# 80755

Wednesday, 01/28/2009 11:36:53 AM

Wednesday, January 28, 2009 11:36:53 AM

Post# of 82595
I think some of the big news is essentially "hidden in plain sight," and few appear to have noticed, but instead appear to have been fooled by the constant baseless claims from "detractor(s.)" I did notice, which is one of the reasons I've been buying. smile

For instance, someone has been harping on the fact that an instrument was down in the lab, at DNAG HQ. However, recall that DNAPrint Genomics and Beckman Coulter signed a sales and marketing agreement... DNAPrint's tests can be run by technicians in labs that buy Beckman's SNPStream DNA sequencing equipment.

Google search that brings up news about this:
http://www.google.com/search?hl=en&safe=off&q=beckman+coulter+dnaprint+snpstream

From the phone calls I've made to some of the AncestryByDNA distributors, considering what they've told me, my sense is that some of them have bought SNPStream equipment, and are running their own tests. The last distributor I called used wording that implied that they're running their own tests, but that the tests are the same as DNAPrint Genomics' tests, and based on the DNAPrint Genomics' patents. (A question is, how much revenue is DNAPrint deriving from such activity? I hope we find out, soon.)

Another point... An article came out yesterday, about St. Jude Children's Hospital and their ongoing research into ALL (acute lymphoblastic leukemia.) We know that St. Jude has been a partner of DNAPrint Genomics (see links below.) Perhaps now they also have their own SNPStream equipment, and are able to run DNAPrint's tests on-site. (Another educated guess.)

St. Jude Children's Hospital -- Inherited Gene Variations Linked to ALL Treatment Response
January 27, 2009
http://www.medpagetoday.com/HematologyOncology/Leukemia/12618

Mentions DNAPrint's involvement/partnership with St. Jude Children's Hospital:

Inherited genes linked to toxicity of leukemia therapy
May 11, 2007
http://www.stjude.org/stjude/v/index.jsp?vgnextoid=4a8094255c443110VgnVCM1000001e0215acRCRD&vgnextchannel=253ff58ab53c1110VgnVCM1000001e0215acRCRD

Excerpt: "Other authors of this work include ... Tony Frudakis (DNAPrint Genomics, Sarasota, Fla.)"

[Note: My opinions are my opinions only. Please don't go by my opinions, in making investment decisions. Everyone needs to do their own research and decision-making, etc. etc. etc.]

Good luck to all! smile

Daniel